These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 35069784)
41. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway. Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689 [TBL] [Abstract][Full Text] [Related]
42. microRNA-944 inhibits breast cancer cell proliferation and promotes cell apoptosis by reducing SPP1 through inactivating the PI3K/Akt pathway. Zhang Y; Li S; Cui X; Wang Y Apoptosis; 2023 Dec; 28(11-12):1546-1563. PubMed ID: 37486406 [TBL] [Abstract][Full Text] [Related]
43. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer. Wang JR; Liu B; Zhou L; Huang YX Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803 [TBL] [Abstract][Full Text] [Related]
44. NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway. Zhu LL; Shi JJ; Guo YD; Yang C; Wang RL; Li SS; Gan DX; Ma PX; Li JQ; Su HC Neoplasma; 2023 Apr; 70(2):272-286. PubMed ID: 37226932 [TBL] [Abstract][Full Text] [Related]
45. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway. Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430 [TBL] [Abstract][Full Text] [Related]
46. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6. Liu Y; Liang G; Wang H; Liu Z Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502 [TBL] [Abstract][Full Text] [Related]
47. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Zhang S; Wang M; Li Q; Zhu P Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1. Liu DZ; Chang B; Li XD; Zhang QH; Zou YH Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066 [TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis. Cheng L; Xing Z; Zhang P; Xu W Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530 [TBL] [Abstract][Full Text] [Related]
50. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55. Yin Y; Cai J; Meng F; Sui C; Jiang Y Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704 [TBL] [Abstract][Full Text] [Related]
51. MEG3 overexpression inhibits the tumorigenesis of breast cancer by downregulating miR-21 through the PI3K/Akt pathway. Zhu M; Wang X; Gu Y; Wang F; Li L; Qiu X Arch Biochem Biophys; 2019 Jan; 661():22-30. PubMed ID: 30389444 [TBL] [Abstract][Full Text] [Related]
52. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
53. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563 [TBL] [Abstract][Full Text] [Related]
54. Downregulated microRNA-135a ameliorates rheumatoid arthritis by inactivation of the phosphatidylinositol 3-kinase/AKT signaling pathway via phosphatidylinositol 3-kinase regulatory subunit 2. Qu Y; Zhang YP; Wu J; Jie LG; Deng JX; Zhao DB; Yu QH J Cell Physiol; 2019 Aug; 234(10):17663-17676. PubMed ID: 30912120 [TBL] [Abstract][Full Text] [Related]
55. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway. Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066 [TBL] [Abstract][Full Text] [Related]
56. Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT. Zheng Z; Zhang Y; Zhang Z; Yang Y; Song T Med Sci Monit; 2017 Mar; 23():1277-1285. PubMed ID: 28288092 [TBL] [Abstract][Full Text] [Related]
57. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway. Liu Y; Yang H Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2. Yu L; Chen J; Liu Y; Zhang Z; Duan S Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929 [TBL] [Abstract][Full Text] [Related]
59. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. Zheng J; Liu C; Shi J; Wen K; Wang X Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077 [TBL] [Abstract][Full Text] [Related]
60. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T). Li L; Li Q Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]